Robert Glynne-Jones

11PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedSolid tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 09, 2026
Body mass index, adjuvant chemotherapy, toxicity, and survival in non-metastatic colorectal cancer: an individual participant data meta-analysis (OCTOPUS).

|Apr 15, 2025
Evaluation of prognostic models to improve prediction of metastasis in patients following potentially curative treatment for primary colorectal cancer: the PROSPECT trial.

Vicky Goh, Susan Mallett, Manuel Rodriguez-Justo

|Mar 02, 2024
Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.

Rob Glynne-Jones, Mark Harrison

|Oct 27, 2023
Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited.

Emmanouil Fokas, J Joshua Smith, Julio Garcia-Aguilar

|Mar 02, 2023
TNT and local recurrence in the RAPIDO trial - untangling the puzzle.

Robert Glynne-Jones, James Hollingshead

|Apr 20, 2022
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

E Van Cutsem, I Danielewicz, M P Saunders

Pageof 2

Frequent Collaborators

2 joint publications

J Joshua Smith

2 joint publications

Emmanouil Fokas

2 joint publications

Julio Garcia-Aguilar

1 joint publications

Andrew G Renehan